Lloyd Laboratories Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Lloyd Laboratories Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $669.0K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Lloyd Laboratories Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $669.0K Trade | TransData Nexus

Lloyd Laboratories Private Limited

Indian Pharmaceutical Exporter · Respiratory Specialist · $669.0K Total Trade · DGFT Verified

Lloyd Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $669.0K across 2 products in 1 therapeutic categories. Based on 19 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Salmeterol ($392.8K), Fluticasone ($276.2K), .

Lloyd Laboratories Private Limited — Export Portfolio & Destination Treemap

Lloyd Laboratories Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Lloyd Laboratories Private Limited? — Company Overview & Market Position

Lloyd Laboratories Private Limited, incorporated on September 20, 2005, is a private unlisted company based in Chennai, Tamil Nadu, India. The company is classified as a non-government entity limited by shares, with an authorized capital of ₹50 million and a paid-up capital of ₹42.892 million. The registered office is located at No:15, Gopala Krishna Road, T Nagar, Chennai, Tamil Nadu 600017, India.

The company's business activities fall under the manufacturing sector, specifically in the production of chemicals and chemical products. As of the latest available data, Lloyd Laboratories has a workforce of approximately 92,000 employees. The company's website is not specified in the available sources.

What Does Lloyd Laboratories Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Salmeterol$392.8K 2Fluticasone$276.2K

Product Portfolio — Top 2 by Export Value

Lloyd Laboratories Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Salmeterol	Respiratory	$392.8K	11	0.5%	10
2	Fluticasone	Respiratory	$276.2K	8	0.1%	14

Lloyd Laboratories Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $669.0K. The top category is Respiratory (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Lloyd Laboratories Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Lloyd Laboratories Private Limited specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's manufacturing facilities are located in Chennai, Tamil Nadu, India. Specific details regarding plant capacities and specializations are not available in the provided sources.

3Key Leadership

The board of directors of Lloyd Laboratories Private Limited comprises:

Lloyd Dizon Balajadia
Dennis Dizon Balajadia
Aditya Baid
Suryadevara Srinivas
Zenaida Dizon Balajadia

Specific roles and responsibilities of these directors are not detailed in the available sources.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Lloyd Laboratories Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Lloyd Laboratories Private Limited has engaged in exporting pharmaceutical products, with a total export value of $669,000 USD across 19 shipments. The exported products include Salmeterol and Fluticasone, both within the respiratory therapeutic category. However, specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not available in the provided sources.

2Emerging Markets

The company's export data indicates a focus on the respiratory therapeutic category, with Salmeterol and Fluticasone being the primary products. However, specific information regarding market penetration in Africa, Latin America, and Southeast Asia, as well as WHO prequalification status, is not available in the provided sources.

3Geographic Strategy

Lloyd Laboratories Private Limited's export portfolio is concentrated entirely on respiratory products, specifically Salmeterol and Fluticasone. This indicates a high portfolio concentration risk. Diversification into other therapeutic categories and geographic markets could mitigate this risk and align with strategic growth objectives.

Lloyd Laboratories Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history for Lloyd Laboratories Private Limited is not available in the provided sources.

2WHO & EU GMP

Details regarding WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status for Lloyd Laboratories Private Limited are not available in the provided sources.

3CDSCO & Indian Regulatory

Specific information regarding Central Drugs Standard Control Organisation (CDSCO) manufacturing licenses, state drug controller approvals, and export No Objection Certificates (NOCs) for Lloyd Laboratories Private Limited is not available in the provided sources.

4Recent Regulatory Actions

Lloyd Laboratories Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Specific information regarding top competitors in overlapping categories, market share comparisons, and head-to-head analyses for Lloyd Laboratories Private Limited is not available in the provided sources.

2Key Differentiators

Lloyd Laboratories Private Limited's focus on the respiratory therapeutic category, particularly in the production of Salmeterol and Fluticasone, may serve as a key differentiator in the market. However, specific unique strengths and competitive advantages are not detailed in the available sources.

3Strategic Position

The company's current strategic direction appears to be concentrated on the respiratory therapeutic category. Expanding into other therapeutic areas and diversifying its product portfolio could enhance its market position and align with future growth objectives.

TransData Nexus Research · DGFT export records, industry analysisMar 2026

Buyer Due Diligence Brief — Evaluating Lloyd Laboratories Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Lloyd Laboratories Private Limited has demonstrated consistent export activity, with a total export value of $669,000 USD across 19 shipments. The company's focus on respiratory products indicates a specialized manufacturing capability. However, specific reliability indicators and a comprehensive track record are not available in the provided sources.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the company's registration status with the U.S. Food and Drug Administration.
WHO-GMP Certification: Verify compliance with World Health Organization Good Manufacturing Practices.
EU GMP Certification: Ensure adherence to European Union Good Manufacturing Practices.
ISO Certification: Check for relevant International Organization for Standardization certifications.

Frequently Asked Questions — Lloyd Laboratories Private Limited

How many pharmaceutical products does Lloyd Laboratories Private Limited export from India?

Lloyd Laboratories Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Salmeterol ($392.8K), Fluticasone ($276.2K). Total export value is $669.0K.

What is Lloyd Laboratories Private Limited's total pharmaceutical export value?

Lloyd Laboratories Private Limited's total pharmaceutical export value is $669.0K, based on 19 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Lloyd Laboratories Private Limited cover?

Lloyd Laboratories Private Limited exports across 1 therapeutic categories. The largest are Respiratory (100.0%, 2 products).

Get Full Lloyd Laboratories Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.